检索

标题
作者
The relationship between the level of Lр(а) and the prevalence of atherosclerosis among young patients
Klesareva E., Afanasieva O., Sherstyuk E., Tmoyan N., Razova O., Tyurina A., Afanasieva M., Ezhov M., Pokrovsky S.
Features of the upper gastrointestinal tract mucous membrane state in patients with atherosclerosis of the mesenteric arteries
Selyanina A., Dolgushina A., Kusnezowa A., Genkel V., Olevskaya E., Nikushkina K., Khikhlova A.
Albuminuria as a marker of atherosclerosis burden and a possible predictor of adverse events in patients with polyvascular disease
Shakhmatova O., Komarov A., Krivosheeva E., Dobrovolsky A., Titaeva E., Amelyushkina V., Gomyranova N., Panchenko E.
Prognostic significance of equivalent density of calcium deposits of coronary arteries in men with osteopenic syndrome and prior coronary artery bypass grafting: prospective study
Kokov A., Masenko V., Barbarash O.
Atherosclerosis and cardiovascular risk in patients with inflammatory bowel disease
Mironova O., Isaikina M., Khasieva S.
The association of lipoprotein(a) and apolipoprotein(a) phenotypes with peripheral artery disease
Tmoyan N., Ezhov M., Afanasieva O., Klesareva E., Razova O., Kukharchuk V., Pokrovsky S.
Modern methods of assessment of physiological significance of coronary lesions: A review
Mironova O., Isaev G., Berdysheva M., Shakhnovich R., Fomin V.
Atherosclerosis of peripheral arteries in patients with coronary artery disease and type 2 diabetes mellitus
Genkel V., Salashenko A., Shamaeva T., Sumerkina V., Nikushkina K., Shaposhnik I.
Do the patients with peripheral atherosclerosis need to a medical therapy before the revascularization?
Barbarash O., Kashtalap V.
Leptin and leptin receptor evaluation in atherosclerotic plaques in patients with type 2 diabetes mellitus
Dimitrova D., Mikhailov I., Tokarev K., Michurova M., Gorbacheva A., Danilova N., Malkov P., Kalashnikov V.
Polyvascular disease in patients with myocardial infarction and chronic kidney disease
Karetnikova V., Kalaeva V., Evseeva M., Gruzdeva O., Zykov M., Kashtalap V., Barbarash O.
Asymptomatic atherosclerosis of the brachiocephalic arteries: Current approaches to diagnosis and treatment
Kopylov F., Bykova A., Shchekochikhin D., Elmanaa K., Dzyundzya A., Vasilevsky Y., Simakov S.
Consecutive formation of the functions of high-, low-density and very-low-density lipoproteins during phylogenesis. Unique algorithm of the effects of lipid-lowering drugs
Titov V., Rozhkova T., Aripovsky A.
Comparative characteristics of carotid atherosclerosis in patients with hypertension concurrent with chronic coronary heart disease among the indigenous and non-indigenous population of the Yamal-Nenets Autonomic District
Gapon L., Sereda T., Leont'eva A., Gul'tiaeva E.
Trends in the risk factors and signs of subclinical atherosclerosis in subjects at low and moderate risk according to the SCORE scale in different medical management tactics: Two-year follow-up results
Urazalina S., Boĭtsov S., Balakhonova T., Kukharchuk V., Karpov I.
Some problems of pathogenesis and clinical symptoms of atherosclerosis (coronary heart disease, hypertension) in the Far North
Tikhonov D., Nikolaev V., Sedalishchev V., Tikhonov D., Nikolaev V., Sedalischev V.
Prophylaxis of cardiovascular diseases in rheumatoid arthritis
Novikova D., Popkova T., Nasonov E., Novikova D., Popkova T., Nasonov E.
Lupus nephritis as a factor of atherosclerosis risk in patients with systemic lupus erythematosus
Serikova S., Kozlovskaia N., Shilov E.
Practical aspects of "Heart Protection Studies"
Susekov A.
Metabolic, inflammatory and imaging biomarkers in evaluation of coronary atherosclerosis severity in patients with coronary artery disease and diabetes mellitus type 2
Koshelskaya O., Kharitonova O., Kologrivova I., Suslova T., Margolis N., Tereshenkova E., Rybina A., Karpov R.
Therapeutic aspects of the choice of antithrombotic therapy in patients with multifocal lesions of peripheral arteries
Oynotkinova O., Nikonov E., Kryukov E., Baranov A.
Immunogenic lipid markers of atherosclerosis in type 2 diabetic patients on program haemodialysis
Archakova T., Nedosugova L., Nikitina N., Melnichenko A., Sobenin I.
Osteoprotegerin is a new marker of cardiovascular diseases
Verbovoy A., Tsanava I., Mitroshina E., Sharonova L.
Helicobacter pylori infection and extragastroduodenal diseases
Maev I., Andreev D., Kucheryavyi Y.
The risk of developing atherosclerosis and osteoporosis in post-oophorectomy women during hormone replacement therapy
Maĭchuk E., Voevodina I., Makarova I., Mitrokhina T., Iureneva S.
THE ROLE OF DUPLEX SCANNING OF THE CAROTID ARTERIES IN DETECTION OF CORRELATIONS BETWEEN CAROTID AND CORONARY ATHEROSCLEROSIS BY THE RESULTS OF CORONAROANGIOGRAPHY IN PATIENTS WITH STABLE ANGINA
Gaisenok O., Martsevich S., Kalashnikov S., Boshkov V., Shatalova I.
Evidence-based grounds of the efficacy of simvastatin (zocor): 15 years later
Susekov A., Gornyakova N., Zubareva M., Susekov A., Gornyakova N., Zubareva M.
Clinical implication of assessment of heart rate variability in patients with psoriatic arthritis
Novikova D., Korotaeva T., Loginova E., Popkova T., Markelova E., Novikov A., Aleksandrova E., Mach E., Nasonov E., Novikova D., Korotaeva T., Loginova E., Popkova T., Markelova E., Novikov A., Alexandrova E., Mach E., Nasonov E.
Soluble CD40 Ligand in systemic lupus erythematosus: link with atherosclerotic vascular affection
Popkova T., Panafidina T., Aleksandrova E., Novikova D., Novikov A., Alekberova Z., Mach É., Nasonov E.
Outlook from the past to the future
Chazov E.
Mobile application “Aterostop” for a comprehensive assessment of cardiovascular risk in patients in the Russian population
Sergienko I., Ansheles A., Boytsov S.
Changes in the intestinal microbiota as a risk factor for dyslipidemia, atherosclerosis and the role of probiotics in their prevention
Oynotkinova O., Nikonov E., Demidova T., Baranov A., Kryukov E., Dedov E., Karavashkina E.
Somatic mutation of the V617F JAK2 gene in patients of the cardiovascular diseases
Olkhovskiy I., Gorbenko A., Stolyar M., Grischenko D., Tkachenko O., Martsinkevich T.
Inhibition of HIF-prolyl 4-hydroxylases as a promising approach to the therapy of cardiometabolic diseases
Aitbaev K., Murkamilov I., Fomin V.
Gut microbiota and obesity: Pathogenetic relationships and ways to normalize the intestinal microflora
Drapkina O., Korneeva O.
Markers of visceral adipose tissue metabolic abnormalities in patients with coronary atherosclerosis in relation to the presence of type 2 diabetes mellitus
Gavrilova N., Metelskaya V., Boytsov S., Gumanova N., Yarovaya E.
Risk factors for and prognostic value of multifocal atherosclerosis in patients with diabetes mellitus
Gracheva S., Biragova M., Glazunova A., Klefortova I., Shamkhalova M., Dzhavelidze M., Soldatova T., Il'in A., Shestakova M., Tugeeva É., Buziashvili I.
TOCILIZUMAB IMPACT ON BLOOD CHOLESTERINE TRANSPORT AND EARLY MANIFESTATION OF ATHEROSCLEROSIS IN PATIENTS WITH RHEUMATOID ARTHRITIS
Popkova T., Novikova D., Panasyuk E., Avdeeva A., Udachkina E., Alexandrova E., Novikov A., Volkov A., Nasonov E.
Coronary artery necroses and calcification in chronic coronary heart disease
Zhdanov V., Cherpachenko N., Drobkova I., Veselova S., Shlychkova T., Zhdanov V., Cherpachenko N., Drobkova I., Veselova S., Shlychkova T.
Cardiovascular risk in psoriatic arthritis
Badokin V., Yanysheva A., Aleksandrova E., Mach E., Popkova T., Badokin V., Yanysheva A., Alexandrova E., Mach E., Popkova T.
Painless myocardial ischemia in patients with rheumatoid arthritis
Striuk R., Leonova E., Tedikova N., Gosteva O.
Role of inflammatory and infectious factors in the development of atherosclerosis
Rebrov A., Voskoboi I.
Cardio-ankle vascular index (CAVI) in diagnostics, risk and severity evaluation of magistral vessels lesion in patients with cardio-vascular diseases and type 2 diabetes
Verner V., Mel’nik M., Knjazeva S.
Upper gastrointestinal bleeding in patients with stable coronary artery disease (registry of antithrombotic therapy “REGATТA” results)
Shakhmatova O., Komarov A., Korobkova V., Yarovaya E., Andreevskaya M., Shuleshova A., Panchenko E.
Preprocedural high - sensitivity C-reactive protein (hsCRP) decrease during intensive atorvastatin therapy: the presumable impact on atherosclerosis progression after coronary stenting
Shchinova A., Shlevkova G., Filatova A., Potekhina A., Osokina A., Romasov I., Zharova E., Noeva E., Samko A., Masenko V., Arefieva T., Provatorov S.
Atherosclerosis: perspectives of anti-inflammatory therapy
Nasonov E., Popkova T.
The biological activity of high-density lipoprotein fractions and their role in the development of cardiovascular diseases
Babintseva Y., Camont L., Chapman J., Lhomme M., Karagodin V., Kontush A., Orekhov A.
Risk factors and glycation end products in patients with different forms of coronary heart disease and type 2 diabetes mellitus
Ivannikova E., Kalashnikov V., Smirnova O., Kononenko I., Kuznetsov A., Terekhin S.
Clinical guidelines for the diagnosis and treatment of pulmonary hypertension
Pylaeva E., Potekhina A., Provatorov S., Raskina K., RulEva N., Masenko V., Noeva E., Krasnikova T., Aref'eva T.
Perspectives of molecular visualization in cardiology
Sergienko V., Samoylenko L., Sergienko V., Samoilenko L.
1 - 50 的 100 信息 1 2 > >> 

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回(例如,隐含AND)
  • 使用OR结合多个检索词,便于查找含有这些检索词的文章,例如education OR research
  • 使用括号来创建更复杂的查询; 例如:archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如: "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如:online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语

##common.cookie##